223 related articles for article (PubMed ID: 28332632)
1. Loss of chromosome Y leads to down regulation of KDM5D and KDM6C epigenetic modifiers in clear cell renal cell carcinoma.
Arseneault M; Monlong J; Vasudev NS; Laskar RS; Safisamghabadi M; Harnden P; Egevad L; Nourbehesht N; Panichnantakul P; Holcatova I; Brisuda A; Janout V; Kollarova H; Foretova L; Navratilova M; Mates D; Jinga V; Zaridze D; Mukeria A; Jandaghi P; Brennan P; Brazma A; Tost J; Scelo G; Banks RE; Lathrop M; Bourque G; Riazalhosseini Y
Sci Rep; 2017 Mar; 7():44876. PubMed ID: 28332632
[TBL] [Abstract][Full Text] [Related]
2. Bladder Cancer, Loss of Y Chromosome, and New Opportunities for Immunotherapy.
Mankan AK; Mankan N; de Las Heras B; Ramkissoon SH; Bodriagova O; Vidal L; Grande E; Saini KS
Adv Ther; 2024 Mar; 41(3):885-890. PubMed ID: 38198042
[TBL] [Abstract][Full Text] [Related]
3. ATR inhibition controls aggressive prostate tumors deficient in Y-linked histone demethylase KDM5D.
Komura K; Yoshikawa Y; Shimamura T; Chakraborty G; Gerke TA; Hinohara K; Chadalavada K; Jeong SH; Armenia J; Du SY; Mazzu YZ; Taniguchi K; Ibuki N; Meyer CA; Nanjangud GJ; Inamoto T; Lee GM; Mucci LA; Azuma H; Sweeney CJ; Kantoff PW
J Clin Invest; 2018 Jul; 128(7):2979-2995. PubMed ID: 29863497
[TBL] [Abstract][Full Text] [Related]
4. Y disruption, autosomal hypomethylation and poor male lung cancer survival.
Willis-Owen SAG; Domingo-Sabugo C; Starren E; Liang L; Freidin MB; Arseneault M; Zhang Y; Lu SK; Popat S; Lim E; Nicholson AG; Riazalhosseini Y; Lathrop M; Cookson WOC; Moffatt MF
Sci Rep; 2021 Jun; 11(1):12453. PubMed ID: 34127738
[TBL] [Abstract][Full Text] [Related]
5. Epigenome Aberrations: Emerging Driving Factors of the Clear Cell Renal Cell Carcinoma.
Mehdi A; Riazalhosseini Y
Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28812986
[TBL] [Abstract][Full Text] [Related]
6. Risk prediction for metastasis of clear cell renal cell carcinoma using digital multiplex ligation-dependent probe amplification.
Yoshikawa Y; Yamada Y; Emi M; Atanesyan L; Smout J; de Groot K; Savola S; Nakanishi-Shinkai Y; Kanematsu A; Nojima M; Ohmuraya M; Hashimoto-Tamaoki T; Yamamoto S
Cancer Sci; 2022 Jan; 113(1):297-307. PubMed ID: 34687579
[TBL] [Abstract][Full Text] [Related]
7. Assessment of Y chromosome copy number alterations in non-neoplastic and neoplastic leukocytes of male dogs.
Mochizuki H; Estrada AJ; Boggess M
Vet J; 2024 Apr; 304():106088. PubMed ID: 38412887
[TBL] [Abstract][Full Text] [Related]
8. Loss of chromosome Y in blood, but not in brain, of suicide completers.
Kimura A; Hishimoto A; Otsuka I; Okazaki S; Boku S; Horai T; Izumi T; Takahashi M; Ueno Y; Shirakawa O; Sora I
PLoS One; 2018; 13(1):e0190667. PubMed ID: 29300758
[TBL] [Abstract][Full Text] [Related]
9. Genetic and epigenetic changes in clonal descendants of irradiated human fibroblasts.
Flunkert J; Maierhofer A; Dittrich M; Müller T; Horvath S; Nanda I; Haaf T
Exp Cell Res; 2018 Sep; 370(2):322-332. PubMed ID: 29964050
[TBL] [Abstract][Full Text] [Related]
10. Frequent epigenetic suppression of tumor suppressor gene glutathione peroxidase 3 by promoter hypermethylation and its clinical implication in clear cell renal cell carcinoma.
Liu Q; Jin J; Ying J; Sun M; Cui Y; Zhang L; Xu B; Fan Y; Zhang Q
Int J Mol Sci; 2015 May; 16(5):10636-49. PubMed ID: 25970749
[TBL] [Abstract][Full Text] [Related]
11. Copy number loss of KDM5D may be a predictive biomarker for ATR inhibitor treatment in male patients with pulmonary squamous cell carcinoma.
Ura A; Hayashi T; Komura K; Hosoya M; Takamochi K; Sato E; Saito S; Wakai S; Handa T; Saito T; Kato S; Suzuki K; Yao T;
J Pathol Clin Res; 2024 Jan; 10(1):e350. PubMed ID: 37974379
[TBL] [Abstract][Full Text] [Related]
12. Loss of Y Chromosome in Peripheral Blood of Colorectal and Prostate Cancer Patients.
Noveski P; Madjunkova S; Sukarova Stefanovska E; Matevska Geshkovska N; Kuzmanovska M; Dimovski A; Plaseska-Karanfilska D
PLoS One; 2016; 11(1):e0146264. PubMed ID: 26745889
[TBL] [Abstract][Full Text] [Related]
13. Increased Expression of Y-Encoded Demethylases During Differentiation of Human Male Neural Stem Cells.
Pottmeier P; Doszyn O; Peuckert C; Jazin E
Stem Cells Dev; 2020 Dec; 29(23):1497-1509. PubMed ID: 33040644
[TBL] [Abstract][Full Text] [Related]
14. Two Splice Variants of Y Chromosome-Located Lysine-Specific Demethylase 5D Have Distinct Function in Prostate Cancer Cell Line (DU-145).
Jangravi Z; Tabar MS; Mirzaei M; Parsamatin P; Vakilian H; Alikhani M; Shabani M; Haynes PA; Goodchild AK; Gourabi H; Baharvand H; Salekdeh GH
J Proteome Res; 2015 Sep; 14(9):3492-502. PubMed ID: 26215926
[TBL] [Abstract][Full Text] [Related]
15. CLEC3B is downregulated and inhibits proliferation in clear cell renal cell carcinoma.
Liu J; Liu Z; Liu Q; Li L; Fan X; Wen T; An G
Oncol Rep; 2018 Oct; 40(4):2023-2035. PubMed ID: 30066941
[TBL] [Abstract][Full Text] [Related]
16. High-resolution analysis of DNA copy number alterations and gene expression in renal clear cell carcinoma.
Yoshimoto T; Matsuura K; Karnan S; Tagawa H; Nakada C; Tanigawa M; Tsukamoto Y; Uchida T; Kashima K; Akizuki S; Takeuchi I; Sato F; Mimata H; Seto M; Moriyama M
J Pathol; 2007 Dec; 213(4):392-401. PubMed ID: 17922474
[TBL] [Abstract][Full Text] [Related]
17. Age-related loss of chromosome Y is associated with levels of sex hormone binding globulin and clonal hematopoiesis defined by
Dawoud AAZ; Tapper WJ; Cross NCP
Sci Adv; 2023 Apr; 9(16):eade9746. PubMed ID: 37083525
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal changes in the frequency of mosaic chromosome Y loss in peripheral blood cells of aging men varies profoundly between individuals.
Danielsson M; Halvardson J; Davies H; Torabi Moghadam B; Mattisson J; Rychlicka-Buniowska E; Jaszczyński J; Heintz J; Lannfelt L; Giedraitis V; Ingelsson M; Dumanski JP; Forsberg LA
Eur J Hum Genet; 2020 Mar; 28(3):349-357. PubMed ID: 31654039
[TBL] [Abstract][Full Text] [Related]
19. Integrative analysis of dysregulated microRNAs and mRNAs in multiple recurrent synchronized renal tumors from patients with von Hippel-Lindau disease.
Gattolliat CH; Couvé S; Meurice G; Oréar C; Droin N; Chiquet M; Ferlicot S; Verkarre V; Vasiliu V; Molinié V; Méjean A; Dessen P; Giraud S; Bressac-De-Paillerets B; Gardie B; Tean Teh B; Richard S; Gad S
Int J Oncol; 2018 Oct; 53(4):1455-1468. PubMed ID: 30066860
[TBL] [Abstract][Full Text] [Related]
20. Why loss of Y? A pan-cancer genome analysis of tumors with loss of Y chromosome.
Müller P; Velazquez Camacho O; Yazbeck AM; Wölwer C; Zhai W; Schumacher J; Heider D; Buettner R; Quaas A; Hillmer AM
Comput Struct Biotechnol J; 2023; 21():1573-1583. PubMed ID: 36874157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
